David Wouters
David Wouters has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Sifrim
KU Leuven
8 shared publications - Katy Vandereyken
KU Leuven
6 shared publications - Thierry Voet
KU Leuven
5 shared publications - Johannes Swinnen
Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, 3000 Leuven, Belgium
4 shared publications - Bernard Thienpont
Laboratory for Functional Epigenetics, Department of Human Genetics, KU Leuven, Leuven, Belgium
3 shared publications - Gabriele Partel
VIB-KU Leuven Center for Brain and Disease Research, KU Leuven
3 shared publications
Latest Publications
- Open Access
Modular click-chemistry-based engineering minimally perturbs CRISPR ribonucleoprotein formation for genome imaging applications
CRISPR-Cas9 has become a key genome imaging tool, because of its sequence-specific binding to genomic DNA. To achieve signal amplification or multiplexing, various complex CRISPR-Cas9 modifications were introduced, primarily relying on expression-based delivery. However, these engineering strategies often invoke structural perturbations and their performance remained dictated by vector design and in vivo CRISPR ribonucleoprotein (RNP) assembly. To date, research mainly focused on optimizing the expression-based delivery mechanisms of CRISPR components rather than addressing the engineering itself. Here, we developed a modular SPAAC (bio-orthogonal strain-promoted azide-alkyne cycloaddition) click-chemistry-based strategy for engineering the CRISPR RNP that is completely dissociated from its assembly. We demonstrated that CRISPR can be modified (with fluorophores and DNA) at all stages of RNP in vitro assembly and subsequently validated the technology for genome imaging. Importantly, we also revealed that engineering native CRISPR RNP only after it is being formed, minimizes structural perturbations to the complex and yields a two-fold enhanced accessibility of 'clicked' DNA. Finally, we utilized SPAAC to conjugate non-native RNA-DNA hybrids, regardless of 5'-3' directionality, to develop a covalently-attached rolling-circle signal amplification approach. The modularity and universal nature of our approach holds the potential to deliver significant advances to both CRISPR imaging and prime-editing fields.
Open AccessModular click-chemistry-based engineering minimally perturbs CRISPR ribonucleoprotein formation for genome imaging applications
CRISPR-Cas9 has become a key genome imaging tool, because of its sequence-specific binding to genomic DNA. To achieve signal amplification or multiplexing, various complex CRISPR-Cas9 modifications were introduced, primarily relying on expression-based delivery. However, these engineering strategies often invoke structural perturbations and their performance remained dictated by vector design and in vivo CRISPR ribonucleoprotein (RNP) assembly. To date, research mainly focused on optimizing the expression-based delivery mechanisms of CRISPR components rather than addressing the engineering itself. Here, we developed a modular SPAAC (bio-orthogonal strain-promoted azide-alkyne cycloaddition) click-chemistry-based strategy for engineering the CRISPR RNP that is completely dissociated from its assembly. We demonstrated that CRISPR can be modified (with fluorophores and DNA) at all stages of RNP in vitro assembly and subsequently validated the technology for genome imaging. Importantly, we also revealed that engineering native CRISPR RNP only after it is being formed, minimizes structural perturbations to the complex and yields a two-fold enhanced accessibility of 'clicked' DNA. Finally, we utilized SPAAC to conjugate non-native RNA-DNA hybrids, regardless of 5'-3' directionality, to develop a covalently-attached rolling-circle signal amplification approach. The modularity and universal nature of our approach holds the potential to deliver significant advances to both CRISPR imaging and prime-editing fields.
- Open Access
LipoGrid: A High-Throughput Multi-omics Perturbation Screen Dissects the Genetic Architecture of Lipid Metabolism
Lipids constitute one of the largest and most diverse classes of cellular molecules, sustaining membrane architecture, energy storage, and signaling. Consequently, their dysregulation underlies a broad spectrum of human disease. However, the genetic mechanisms governing lipid homeostasis have remained largely inaccessible, owing to the lack of approaches capable of systematically linking defined genetic perturbations to large-scale changes in cellular lipidome composition. Here we introduce LipoGrid, a spatial mass spectrometry platform that resolves the genetic architecture of lipid metabolism at single-cell resolution. LipoGrid arrays CRISPR/Cas9-perturbed cells on a micropatterned grid and sequentially captures lipidomic and gRNA identity from the same cells, complemented by single-cell RNA sequencing of matched cell populations subjected to the same perturbations. Using this approach, we quantified the relative abundance of 158 distinct lipid species across 143 target genes in a rigorously controlled experimental framework. We find that most gene knockouts produced measurable alterations in lipid composition, often affecting specific lipid classes and molecular subspecies. The screen accurately recapitulated established gene-lipid relationships, including enzyme-substrate specificities, lipid pathway regulators, and disease-associated loss-of-function phenotypes, thereby demonstrating the sensitivity and accuracy of LipoGrid. By jointly profiling transcriptomic and lipidomic responses, we further uncover compensatory feedback mechanisms that buffer the impact of genetic perturbations on the cellular lipidome. Collectively, these findings establish LipoGrid as a scalable multimodal platform for systematically mapping gene-lipid interactions and reveal the regulatory networks linking gene perturbation, transcriptional adaptation, and lipidome remodeling. Highlights: Micropatterned single-cell growth enables spatial lipidomic perturbation screens LipoGrid maps 143 gene knockouts to 158 lipid species and transcriptomic states Perturbed lipidomes reveal compensatory feedback and lipid-class-specific uptake Recovers enzyme substrate specificities and disease-linked lipid signatures
Open AccessLipoGrid: A High-Throughput Multi-omics Perturbation Screen Dissects the Genetic Architecture of Lipid Metabolism
Lipids constitute one of the largest and most diverse classes of cellular molecules, sustaining membrane architecture, energy storage, and signaling. Consequently, their dysregulation underlies a broad spectrum of human disease. However, the genetic mechanisms governing lipid homeostasis have remained largely inaccessible, owing to the lack of approaches capable of systematically linking defined genetic perturbations to large-scale changes in cellular lipidome composition. Here we introduce LipoGrid, a spatial mass spectrometry platform that resolves the genetic architecture of lipid metabolism at single-cell resolution. LipoGrid arrays CRISPR/Cas9-perturbed cells on a micropatterned grid and sequentially captures lipidomic and gRNA identity from the same cells, complemented by single-cell RNA sequencing of matched cell populations subjected to the same perturbations. Using this approach, we quantified the relative abundance of 158 distinct lipid species across 143 target genes in a rigorously controlled experimental framework. We find that most gene knockouts produced measurable alterations in lipid composition, often affecting specific lipid classes and molecular subspecies. The screen accurately recapitulated established gene-lipid relationships, including enzyme-substrate specificities, lipid pathway regulators, and disease-associated loss-of-function phenotypes, thereby demonstrating the sensitivity and accuracy of LipoGrid. By jointly profiling transcriptomic and lipidomic responses, we further uncover compensatory feedback mechanisms that buffer the impact of genetic perturbations on the cellular lipidome. Collectively, these findings establish LipoGrid as a scalable multimodal platform for systematically mapping gene-lipid interactions and reveal the regulatory networks linking gene perturbation, transcriptional adaptation, and lipidome remodeling. Highlights: Micropatterned single-cell growth enables spatial lipidomic perturbation screens LipoGrid maps 143 gene knockouts to 158 lipid species and transcriptomic states Perturbed lipidomes reveal compensatory feedback and lipid-class-specific uptake Recovers enzyme substrate specificities and disease-linked lipid signatures
- Open Access
- 10 July 2026
- Published by Elsevier in SSRN Electronic Journal
Subcellspace: Automated Characterization of Subcellular mRNA Localization Patterns in Spatial Transcriptomics
The localized translation of transcripts is a universal phenomenon across biological domains. Many examples of subcellular RNA localization and their functional importance have been described. However, these examples remain anecdotal, and a more systematic genome and cell-type-wide analysis is needed. Current spatial transcriptomic techniques can characterize hundreds to thousands of transcript species at subcellular resolutions, enabling the large-scale investigation of subcellular mRNA localization. Here we describe SubCellSpace, a computational framework to learn general representations of mRNA localization patterns. By embedding observed single-cell subcellular localization patterns (SLPs) to an interpretable latent space, SubCellSpace can detect and statistically infer the presence of SLPs, uncover colocalizing gene-pairs and characterize cellular heterogeneity for pattern-presentation. We benchmark SubCellSpace in both synthetic and real data, showing it can correctly detect previously described apical/basal polarized genes in the enterocytes of mouse small-intestine, as well as encode the enterocytes’ orientation. Additionally, we provide a tailored spatial transcriptomics validation dataset for benchmarking SLP identification based on transcripts previously described to be enriched near subcellular structures in HEK293T cells. We propose a practical and computationally-efficient classification workflow that automatically detects localized transcript species and quantifies their degree of patterning, while controlling false positive rates. Finally, we showcase SubCellSpace in both supervised and unsupervised settings, to either classify pre-determined SLPs or to explore spatial patterning without specifying pattern types a priori. Automated AI models such as SubCellSpace and their integration in spatial transcriptomics analysis workflows will help characterize previously undiscovered subcellular RNA localization phenomena, providing novel insights into post-transcriptional regulation mechanisms.
- 10 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessSubcellspace: Automated Characterization of Subcellular mRNA Localization Patterns in Spatial Transcriptomics
The localized translation of transcripts is a universal phenomenon across biological domains. Many examples of subcellular RNA localization and their functional importance have been described. However, these examples remain anecdotal, and a more systematic genome and cell-type-wide analysis is needed. Current spatial transcriptomic techniques can characterize hundreds to thousands of transcript species at subcellular resolutions, enabling the large-scale investigation of subcellular mRNA localization. Here we describe SubCellSpace, a computational framework to learn general representations of mRNA localization patterns. By embedding observed single-cell subcellular localization patterns (SLPs) to an interpretable latent space, SubCellSpace can detect and statistically infer the presence of SLPs, uncover colocalizing gene-pairs and characterize cellular heterogeneity for pattern-presentation. We benchmark SubCellSpace in both synthetic and real data, showing it can correctly detect previously described apical/basal polarized genes in the enterocytes of mouse small-intestine, as well as encode the enterocytes’ orientation. Additionally, we provide a tailored spatial transcriptomics validation dataset for benchmarking SLP identification based on transcripts previously described to be enriched near subcellular structures in HEK293T cells. We propose a practical and computationally-efficient classification workflow that automatically detects localized transcript species and quantifies their degree of patterning, while controlling false positive rates. Finally, we showcase SubCellSpace in both supervised and unsupervised settings, to either classify pre-determined SLPs or to explore spatial patterning without specifying pattern types a priori. Automated AI models such as SubCellSpace and their integration in spatial transcriptomics analysis workflows will help characterize previously undiscovered subcellular RNA localization phenomena, providing novel insights into post-transcriptional regulation mechanisms.
- Open Access
SubCellSpace: Automated characterization of subcellular mRNA localization patterns in spatial transcriptomics
The localized translation of transcripts is a universal phenomenon across biological domains. Many examples of subcellular RNA localization and their functional importance have been described. However, these examples remain anecdotal, and a more systematic genome and cell-type-wide analysis is needed. Current spatial transcriptomic techniques can characterize hundreds to thousands of transcript species at subcellular resolutions, enabling the large-scale investigation of subcellular mRNA localization. Here we describe SubCellSpace, a computational framework to learn general representations of mRNA localization patterns. By embedding observed single-cell subcellular localization patterns (SLPs) to an interpretable latent space, SubCellSpace can detect and statistically infer the presence of SLPs, uncover colocalizing gene-pairs and characterize cellular heterogeneity for pattern-presentation. We benchmark SubCellSpace in both synthetic and real data, showing it can correctly detect previously described apical/basal polarized genes in the enterocytes of mouse small-intestine, as well as encode the enterocytes’ orientation. Additionally, we provide a tailored spatial transcriptomics validation dataset for benchmarking SLP identification based on transcripts previously described to be enriched near subcellular structures in HEK293T cells. We propose a practical and computationally-efficient classification workflow that automatically detects localized transcript species and quantifies their degree of patterning, while controlling false positive rates. Finally, we showcase SubCellSpace in both supervised and unsupervised settings, to either classify pre-determined SLPs or to explore spatial patterning without specifying pattern types a priori . Automated AI models such as SubCellSpace and their integration in spatial transcriptomics analysis workflows will help characterize previously undiscovered subcellular RNA localization phenomena, providing novel insights into post-transcriptional regulation mechanisms.
Open AccessSubCellSpace: Automated characterization of subcellular mRNA localization patterns in spatial transcriptomics
The localized translation of transcripts is a universal phenomenon across biological domains. Many examples of subcellular RNA localization and their functional importance have been described. However, these examples remain anecdotal, and a more systematic genome and cell-type-wide analysis is needed. Current spatial transcriptomic techniques can characterize hundreds to thousands of transcript species at subcellular resolutions, enabling the large-scale investigation of subcellular mRNA localization. Here we describe SubCellSpace, a computational framework to learn general representations of mRNA localization patterns. By embedding observed single-cell subcellular localization patterns (SLPs) to an interpretable latent space, SubCellSpace can detect and statistically infer the presence of SLPs, uncover colocalizing gene-pairs and characterize cellular heterogeneity for pattern-presentation. We benchmark SubCellSpace in both synthetic and real data, showing it can correctly detect previously described apical/basal polarized genes in the enterocytes of mouse small-intestine, as well as encode the enterocytes’ orientation. Additionally, we provide a tailored spatial transcriptomics validation dataset for benchmarking SLP identification based on transcripts previously described to be enriched near subcellular structures in HEK293T cells. We propose a practical and computationally-efficient classification workflow that automatically detects localized transcript species and quantifies their degree of patterning, while controlling false positive rates. Finally, we showcase SubCellSpace in both supervised and unsupervised settings, to either classify pre-determined SLPs or to explore spatial patterning without specifying pattern types a priori . Automated AI models such as SubCellSpace and their integration in spatial transcriptomics analysis workflows will help characterize previously undiscovered subcellular RNA localization phenomena, providing novel insights into post-transcriptional regulation mechanisms.
- Open Access
- 22 December 2025
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (1) , 53-66
Axonal Eif5a hypusination controls local translation and mitigates defects in FUS-ALS
Local protein synthesis is vital for neuronal function, but its dysregulation in neurodegenerative diseases remains poorly defined. Here we applied spatial transcriptomics to adult mouse motor nerve axons and cell bodies to enable subcellular mapping. Among transcripts found in mature axons, the most enriched biological process is protein translation, and localization of translation machinery was confirmed using multiplexed single-molecule spatial transcriptomics combined with immunofluorescence. Amyotrophic lateral sclerosis (ALS)-associated mutations in the RNA-binding protein fused in sarcoma (FUS), which suppress local translation, disrupt the compartment-specific RNA signatures, including components of the translation machinery. In particular, eukaryotic initiation factor 5a (Eif5a), a translation factor involved in elongation and termination, is found to be locally impaired in mutant FUS axons with reduced levels of its active hypusinated form. Axon-specific treatment with polyamine spermidine restores Eif5a hypusination and ameliorates mutant FUS-dependent neuronal defects, including suppression of local protein synthesis. Finally, in vivo spermidine treatment reduces ALS-related toxicity in mutant FUS and TDP-43 Drosophila models, which may have implications for therapy development.
- 22 December 2025
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (1) , 53-66
Open AccessAxonal Eif5a hypusination controls local translation and mitigates defects in FUS-ALS
Local protein synthesis is vital for neuronal function, but its dysregulation in neurodegenerative diseases remains poorly defined. Here we applied spatial transcriptomics to adult mouse motor nerve axons and cell bodies to enable subcellular mapping. Among transcripts found in mature axons, the most enriched biological process is protein translation, and localization of translation machinery was confirmed using multiplexed single-molecule spatial transcriptomics combined with immunofluorescence. Amyotrophic lateral sclerosis (ALS)-associated mutations in the RNA-binding protein fused in sarcoma (FUS), which suppress local translation, disrupt the compartment-specific RNA signatures, including components of the translation machinery. In particular, eukaryotic initiation factor 5a (Eif5a), a translation factor involved in elongation and termination, is found to be locally impaired in mutant FUS axons with reduced levels of its active hypusinated form. Axon-specific treatment with polyamine spermidine restores Eif5a hypusination and ameliorates mutant FUS-dependent neuronal defects, including suppression of local protein synthesis. Finally, in vivo spermidine treatment reduces ALS-related toxicity in mutant FUS and TDP-43 Drosophila models, which may have implications for therapy development.
- Open Access
Multi-omics integration and batch correction using a modality-agnostic deep learning framework
State-of-the-art biotechnologies allow the detection of different molecular species on the same biological sample, generating complex highly-dimensional multi-modal datasets. Gaining a holistic understanding of biological phenomena, such as oncogenesis or aging, requires integrating these diverse modalities into low-dimensional data representations while correcting for technical artifacts. Here we present MIMA, a modular, unsupervised AI framework for multi-omics data integration and batch correction. Applied to complex spatial and single-cell datasets, MIMA effectively removes batch effects, while preserving biologically relevant information, and learns representations predictive of expert pathologist annotations. Additionally, it enables cross-modal translation, uncovers molecular patterns not captured by manual annotations, and despite being modality-agnostic performs on par with specialized state-of-the-art tools. MIMA’s flexibility and scalability make it a powerful tool for multimodal data analysis. MIMA provides a foundation for AI-based, multi-omics augmented digital pathology frameworks, offering new opportunities for improved patient stratification and precision medicine through the comprehensive integration of high-dimensional molecular data and histopathological imaging.
Open AccessMulti-omics integration and batch correction using a modality-agnostic deep learning framework
State-of-the-art biotechnologies allow the detection of different molecular species on the same biological sample, generating complex highly-dimensional multi-modal datasets. Gaining a holistic understanding of biological phenomena, such as oncogenesis or aging, requires integrating these diverse modalities into low-dimensional data representations while correcting for technical artifacts. Here we present MIMA, a modular, unsupervised AI framework for multi-omics data integration and batch correction. Applied to complex spatial and single-cell datasets, MIMA effectively removes batch effects, while preserving biologically relevant information, and learns representations predictive of expert pathologist annotations. Additionally, it enables cross-modal translation, uncovers molecular patterns not captured by manual annotations, and despite being modality-agnostic performs on par with specialized state-of-the-art tools. MIMA’s flexibility and scalability make it a powerful tool for multimodal data analysis. MIMA provides a foundation for AI-based, multi-omics augmented digital pathology frameworks, offering new opportunities for improved patient stratification and precision medicine through the comprehensive integration of high-dimensional molecular data and histopathological imaging.
- Open Access
- 15 July 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (7) , e70483
Alzheimer's disease and its co‐pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4
INTRODUCTION: In neurodegenerative dementias, the co‐occurrence and interaction of amyloid β peptide (Aβ), tau pathology, and other pathological lesions confound their individual contributions to neurodegeneration and their modulation by risk factors. METHODS: We analyzed 480 post mortem human brains (ages 50–99) using regression and structural equation models to assess the relationships among Aβ, tau, limbic‐predominant age‐related TDP‐43 encephalopathy neuropathological changes (LATE‐NC), α‐synuclein, other age‐related lesions, and apolipoprotein E ( APOE ) ε4, as well as their effects on CA1 neuronal density, brain weight, and cognitive status. RESULTS: Aβ, tau, LATE‐NC, and amygdala‐predominant α‐synuclein pathology were mutually interdependent. Tau was the strongest predictor of global neurodegeneration, while LATE‐NC primarily, but not exclusively, affected hippocampal neuron loss. Small vessel disease correlated with both LATE‐NC and α‐synuclein, while APOE ε4 was mainly associated with extracellular parenchymal and capillary Aβ pathology. DISCUSSION: Although Alzheimer's disease pathology plays a central role in brain degeneration, coexisting pathologies can both exacerbate and independently contribute to it. These factors should be considered in patient stratification. Highlights: In aging individuals, amyloid β peptide (Aβ), tau pathology, limbic‐predominant age‐related TDP‐43 encephalopathy neuropathological changes (LATE‐NC), and amygdala‐predominant α‐synuclein pathology were interrelated but contributed independently to neurodegeneration. LATE‐NC was the strongest driver of CA1 neuronal loss, while tau burden was the strongest predictor of global brain degeneration. Apolipoprotein E ε4 was associated with both extracellular and capillary Aβ deposits, but not with tau burden. Temporal lobe small vessel disease was associated with both LATE‐NC and amygdala‐predominant α‐synuclein pathology. Neural network models can reliably identify hippocampal pyramidal neurons on hematoxylin‐stained histological slides.
- 15 July 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (7) , e70483
Open AccessAlzheimer's disease and its co‐pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4
INTRODUCTION: In neurodegenerative dementias, the co‐occurrence and interaction of amyloid β peptide (Aβ), tau pathology, and other pathological lesions confound their individual contributions to neurodegeneration and their modulation by risk factors. METHODS: We analyzed 480 post mortem human brains (ages 50–99) using regression and structural equation models to assess the relationships among Aβ, tau, limbic‐predominant age‐related TDP‐43 encephalopathy neuropathological changes (LATE‐NC), α‐synuclein, other age‐related lesions, and apolipoprotein E ( APOE ) ε4, as well as their effects on CA1 neuronal density, brain weight, and cognitive status. RESULTS: Aβ, tau, LATE‐NC, and amygdala‐predominant α‐synuclein pathology were mutually interdependent. Tau was the strongest predictor of global neurodegeneration, while LATE‐NC primarily, but not exclusively, affected hippocampal neuron loss. Small vessel disease correlated with both LATE‐NC and α‐synuclein, while APOE ε4 was mainly associated with extracellular parenchymal and capillary Aβ pathology. DISCUSSION: Although Alzheimer's disease pathology plays a central role in brain degeneration, coexisting pathologies can both exacerbate and independently contribute to it. These factors should be considered in patient stratification. Highlights: In aging individuals, amyloid β peptide (Aβ), tau pathology, limbic‐predominant age‐related TDP‐43 encephalopathy neuropathological changes (LATE‐NC), and amygdala‐predominant α‐synuclein pathology were interrelated but contributed independently to neurodegeneration. LATE‐NC was the strongest driver of CA1 neuronal loss, while tau burden was the strongest predictor of global brain degeneration. Apolipoprotein E ε4 was associated with both extracellular and capillary Aβ deposits, but not with tau burden. Temporal lobe small vessel disease was associated with both LATE‐NC and amygdala‐predominant α‐synuclein pathology. Neural network models can reliably identify hippocampal pyramidal neurons on hematoxylin‐stained histological slides.
- Open Access
Alzheimer’s disease and its co-pathologies: implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4
INTRODUCTION: In neurodegenerative dementias, the co-occurrence and interaction of Aβ, tau, and other pathological lesions confound their individual contributions to neurodegeneration and their modulation by risk factors. METHODS: We analyzed 480 post-mortem human brains (ages 50–99) using regression and structural equation models to assess the relationships among Aβ, tau, LATE-NC, α-synuclein, other age-related lesions, and APOE ε4, as well as their effects on CA1 neuronal density, brain weight, and cognitive status. RESULTS: Aβ, tau, LATE-NC, and amygdala-predominant α-synuclein pathology were highly interconnected. Tau was the strongest predictor of global neurodegeneration, while LATE-NC primarily, but not exclusively, affected hippocampal neuron loss. Small vessel disease correlated with both LATE-NC and α-synuclein, while APOE ε4 was mainly associated with extracellular and capillary Aβ. DISCUSSION: Although Alzheimer’s pathology plays a central role in brain degeneration, coexisting pathologies can both exacerbate and independently contribute to it. These factors should be considered in patient stratification.
Open AccessAlzheimer’s disease and its co-pathologies: implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4
INTRODUCTION: In neurodegenerative dementias, the co-occurrence and interaction of Aβ, tau, and other pathological lesions confound their individual contributions to neurodegeneration and their modulation by risk factors. METHODS: We analyzed 480 post-mortem human brains (ages 50–99) using regression and structural equation models to assess the relationships among Aβ, tau, LATE-NC, α-synuclein, other age-related lesions, and APOE ε4, as well as their effects on CA1 neuronal density, brain weight, and cognitive status. RESULTS: Aβ, tau, LATE-NC, and amygdala-predominant α-synuclein pathology were highly interconnected. Tau was the strongest predictor of global neurodegeneration, while LATE-NC primarily, but not exclusively, affected hippocampal neuron loss. Small vessel disease correlated with both LATE-NC and α-synuclein, while APOE ε4 was mainly associated with extracellular and capillary Aβ. DISCUSSION: Although Alzheimer’s pathology plays a central role in brain degeneration, coexisting pathologies can both exacerbate and independently contribute to it. These factors should be considered in patient stratification.
- Open Access
- 18 October 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (42) , eadp6164
Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis
A major therapeutic barrier in melanoma is the coexistence of diverse cellular states marked by distinct metabolic traits. Transitioning from a proliferative to an invasive melanoma phenotype is coupled with increased ferroptosis vulnerability. However, the regulatory circuits controlling ferroptosis susceptibility across melanoma cell states are unknown. In this work, we identified Apolipoprotein E ( APOE ) as the top lipid-metabolism gene segregating the melanoma MITF high /AXL low proliferative/ferroptosis-resistant from MITF low /AXL high invasive/ferroptosis-sensitive state. Mechanistically, ApoE secreted by the MITF high /AXL low cells protects the invasive phenotype from ferroptosis-inducing agents by reducing the content of peroxidation-prone polyunsaturated fatty acids and boosting GPX4 levels both in vitro and in vivo. Whole-exome sequencing indicates that APOE high expression in patients with melanoma is associated with resistance to ferroptosis, regardless of APOE germline status. In aggregate, we found a ferroptosis-resistance mechanism between melanoma cell states relying on secreted ApoE and APOE high expression as a potential biomarker for poor ferroptosis response in melanoma.
- 18 October 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (42) , eadp6164
Open AccessSecreted Apoe rewires melanoma cell state vulnerability to ferroptosis
A major therapeutic barrier in melanoma is the coexistence of diverse cellular states marked by distinct metabolic traits. Transitioning from a proliferative to an invasive melanoma phenotype is coupled with increased ferroptosis vulnerability. However, the regulatory circuits controlling ferroptosis susceptibility across melanoma cell states are unknown. In this work, we identified Apolipoprotein E ( APOE ) as the top lipid-metabolism gene segregating the melanoma MITF high /AXL low proliferative/ferroptosis-resistant from MITF low /AXL high invasive/ferroptosis-sensitive state. Mechanistically, ApoE secreted by the MITF high /AXL low cells protects the invasive phenotype from ferroptosis-inducing agents by reducing the content of peroxidation-prone polyunsaturated fatty acids and boosting GPX4 levels both in vitro and in vivo. Whole-exome sequencing indicates that APOE high expression in patients with melanoma is associated with resistance to ferroptosis, regardless of APOE germline status. In aggregate, we found a ferroptosis-resistance mechanism between melanoma cell states relying on secreted ApoE and APOE high expression as a potential biomarker for poor ferroptosis response in melanoma.
- Open Access
Integration of Multiple Spatial Omics Modalities Reveals Unique Insights into Molecular Heterogeneity of Prostate Cancer
Recent advances in spatial omics methods are revolutionising biomedical research by enabling detailed molecular analyses of cells and their interactions in their native state. As most technologies capture only a specific type of molecules, there is an unmet need to enable integration of multiple spatial-omics datasets. This, however, presents several challenges as these analyses typically operate on separate tissue sections at disparate spatial resolutions. Here, we established a spatial multi-omics integration pipeline enabling co-registration and granularity matching, and applied it to integrate spatial transcriptomics, mass spectrometry-based lipidomics, single nucleus RNA-seq and histomorphological information from human prostate cancer patient samples. This approach revealed unique correlations between lipids and gene expression profiles that are linked to distinct cell populations and histopathological disease states and uncovered molecularly different subregions not discernible by morphology alone. By its ability to correlate datasets that span across the biomolecular and spatial scale, the application of this novel spatial multi-omics integration pipeline provides unprecedented insight into the intricate interplay between different classes of molecules in a tissue context. In addition, it has unique hypothesis-generating potential, and holds promise for applications in molecular pathology, biomarker and target discovery and other tissue-based research fields.
Open AccessIntegration of Multiple Spatial Omics Modalities Reveals Unique Insights into Molecular Heterogeneity of Prostate Cancer
Recent advances in spatial omics methods are revolutionising biomedical research by enabling detailed molecular analyses of cells and their interactions in their native state. As most technologies capture only a specific type of molecules, there is an unmet need to enable integration of multiple spatial-omics datasets. This, however, presents several challenges as these analyses typically operate on separate tissue sections at disparate spatial resolutions. Here, we established a spatial multi-omics integration pipeline enabling co-registration and granularity matching, and applied it to integrate spatial transcriptomics, mass spectrometry-based lipidomics, single nucleus RNA-seq and histomorphological information from human prostate cancer patient samples. This approach revealed unique correlations between lipids and gene expression profiles that are linked to distinct cell populations and histopathological disease states and uncovered molecularly different subregions not discernible by morphology alone. By its ability to correlate datasets that span across the biomolecular and spatial scale, the application of this novel spatial multi-omics integration pipeline provides unprecedented insight into the intricate interplay between different classes of molecules in a tissue context. In addition, it has unique hypothesis-generating potential, and holds promise for applications in molecular pathology, biomarker and target discovery and other tissue-based research fields.